Tech Company Financing Transactions
Cofactor Genomics Funding Round
Cofactor Genomics, based in San Francisco, scored investment capital from Ascension Ventures and LabCorp.
Transaction Overview
Company Name
Announced On
12/16/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to support continued expansion of its predictive immunotherapy diagnostic portfolio.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
300 Brannan St.
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Website
Email Address
Overview
Cofactor Genomics is an RNA products, RNA diagnostics, and RNA-seq service provider. We are the leaders in RNA Sequencing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jarret Glasscock
Chief Medical Officer
Eric Duncavage
Chief Operating Officer
David Messina
Chief Scientific Officer
Jon Armstrong
Browse more venture capital transactions:
Prev: 12/16/2025: Scylos venture capital transaction
Next: 12/16/2025: Aeovian Pharmaceuticals venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs